Expression of Interleukin ‐17 in Primary Sjögren's Syndrome and the Correlation with Disease Severity: A Systematic Review and Meta‐Analysis

In conclusion, the expression of IL‐17 is obviously increased in pSS patients, especially among those without immunosuppressive treatment. In addition, IL‐17 level correlates with the disease severity of pSS. These findings demonstrate the significance of IL‐17 overexpression in pSS patients, and may provide insights for the development of therapeutic interventions targeting IL‐17 for pSS. This article is protected by copyright. All rights reserved.
Source: Scandinavian Journal of Immunology - Category: Allergy & Immunology Authors: Tags: Regular Manuscript Source Type: research